Sharanjit Kaur, et al. “Effectiveness of Trimetazidine, a Cytoprotective Agent in Ischemic Heart Disease”. Technological Innovation in Pharmaceutical Research Vol. 6, June 2021, pp. 65-72, doi:10.9734/bpi/tipr/v6/10092D.